Jane J. Zara

Array ( [id] => 13065845 [patent_doc_number] => 10053697 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2018-08-21 [patent_title] => Programmable alternative splicing devices and uses thereof [patent_app_type] => utility [patent_app_number] => 14/991837 [patent_app_country] => US [patent_app_date] => 2016-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 13 [patent_no_of_words] => 11153 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14991837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10776613 [patent_doc_number] => 20160122769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-05 [patent_title] => 'METHOD OF SCREENING FOR CHAPERONIN MODULATOR' [patent_app_type] => utility [patent_app_number] => 14/989892 [patent_app_country] => US [patent_app_date] => 2016-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7717 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14989892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11068000 [patent_doc_number] => 20160264965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-15 [patent_title] => 'RNA Targeting in Alpha-Synucleinopathies' [patent_app_type] => utility [patent_app_number] => 14/986873 [patent_app_country] => US [patent_app_date] => 2016-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6685 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14986873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13549087 [patent_doc_number] => 20180326091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-15 [patent_title] => NATURALLY OCCURRING miRNA FOR CONTROLLING GENE EXPRESSION, AND USE OF SAME [patent_app_type] => utility [patent_app_number] => 15/539226 [patent_app_country] => US [patent_app_date] => 2015-12-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18898 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12058508 [patent_doc_number] => 20170334852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-23 [patent_title] => 'CATIONIC LIPID' [patent_app_type] => utility [patent_app_number] => 15/533576 [patent_app_country] => US [patent_app_date] => 2015-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16098 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15533576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16168189 [patent_doc_number] => 10709729 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-14 [patent_title] => Compositions and methods for inhibiting expression of ADAMTS-5 and ADAM17 [patent_app_type] => utility [patent_app_number] => 15/539671 [patent_app_country] => US [patent_app_date] => 2015-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 25502 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11929771 [patent_doc_number] => 09796756 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-24 [patent_title] => 'Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA' [patent_app_type] => utility [patent_app_number] => 14/972385 [patent_app_country] => US [patent_app_date] => 2015-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 24332 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14972385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12002136 [patent_doc_number] => 20170306291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'RECOMBINANTLY ENGINEERED DIAZOTROPHS FOR WHOLE CELL HYDROCARBON PRODUCTION AND METHODS FOR MAKING AND USING THEM' [patent_app_type] => utility [patent_app_number] => 15/536653 [patent_app_country] => US [patent_app_date] => 2015-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4914 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15536653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12092808 [patent_doc_number] => 20170349902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-07 [patent_title] => 'SINGLE-STRANDED NUCLEIC ACID MOLECULE FOR INHIBITING TGF-BETA1 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 15/536006 [patent_app_country] => US [patent_app_date] => 2015-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17030 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15536006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12112968 [patent_doc_number] => 09868951 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-16 [patent_title] => 'Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells' [patent_app_type] => utility [patent_app_number] => 14/955539 [patent_app_country] => US [patent_app_date] => 2015-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 15744 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14955539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15320959 [patent_doc_number] => 20200000809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-02 [patent_title] => USE OF AKT2 IN DIAGNOSIS AND TREATMENT OF TUMOR [patent_app_type] => utility [patent_app_number] => 15/778479 [patent_app_country] => US [patent_app_date] => 2015-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13353 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12546879 [patent_doc_number] => 10011834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-03 [patent_title] => Methods and compositions for the specific inhibition of HIF-1a by double-stranded RNA [patent_app_type] => utility [patent_app_number] => 14/952909 [patent_app_country] => US [patent_app_date] => 2015-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 98271 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14952909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17322606 [patent_doc_number] => 11213593 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-04 [patent_title] => Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates [patent_app_type] => utility [patent_app_number] => 15/527840 [patent_app_country] => US [patent_app_date] => 2015-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 32 [patent_no_of_words] => 17033 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15527840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13037973 [patent_doc_number] => 10041111 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-07 [patent_title] => Method for detecting and quantifying biomaterials by using activity of nucleic acid polymerase regulated by target material [patent_app_type] => utility [patent_app_number] => 15/524093 [patent_app_country] => US [patent_app_date] => 2015-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 12750 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15524093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11084121 [patent_doc_number] => 20160281083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-29 [patent_title] => 'MODULATION OF TIMP1 AND TIMP2 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 14/927856 [patent_app_country] => US [patent_app_date] => 2015-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 73150 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14927856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10762246 [patent_doc_number] => 20160108400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-21 [patent_title] => 'Single-Stranded Nucleic Acid Molecule for Controlling Gene Expression' [patent_app_type] => utility [patent_app_number] => 14/927270 [patent_app_country] => US [patent_app_date] => 2015-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 39399 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14927270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10700794 [patent_doc_number] => 20160046942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-18 [patent_title] => 'TREATMENT OF SEX HORMONE BINDING GLOBULIN (SHBG) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SHBG' [patent_app_type] => utility [patent_app_number] => 14/922954 [patent_app_country] => US [patent_app_date] => 2015-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25313 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14922954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12449229 [patent_doc_number] => 09982263 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-29 [patent_title] => Conserved HBV and HCV sequences useful for gene silencing [patent_app_type] => utility [patent_app_number] => 14/921510 [patent_app_country] => US [patent_app_date] => 2015-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 15 [patent_no_of_words] => 34686 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14921510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11751543 [patent_doc_number] => 09709552 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-18 [patent_title] => 'Use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma' [patent_app_type] => utility [patent_app_number] => 14/920612 [patent_app_country] => US [patent_app_date] => 2015-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 44 [patent_no_of_words] => 22716 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14920612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10686138 [patent_doc_number] => 20160032283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'RANDOM RNAi LIBRARIES, METHODS OF GENERATING SAME, AND SCREENING METHODS UTILIZING SAME' [patent_app_type] => utility [patent_app_number] => 14/886378 [patent_app_country] => US [patent_app_date] => 2015-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 32143 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14886378 [rel_patent_id] =>[rel_patent_doc_number] =>)